Efficacy and safety of tocilizumab in Behçet’s syndrome with refractory arterial lesions: a single-centre observational cohort study in China

OBJECTIVE: The aim of this observational cohort study was to assess the effectiveness and safety of the IL-6-receptor inhibitor tocilizumab (TCZ) in Behçet’s syndrome (BS) with refractory arterial involvement. METHODS: Ten patients admitted to the Rheumatology and Immunology Department of Peking Uni...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhong, Hua, Liu, Tian, Liu, Yanying, Zhang, Xiaoying, Zhou, Yunshan, Su, Yin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Clinical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9258597/
https://www.ncbi.nlm.nih.gov/pubmed/34791076
http://dx.doi.org/10.1093/rheumatology/keab840

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9258597/
https://www.ncbi.nlm.nih.gov/pubmed/34791076
http://dx.doi.org/10.1093/rheumatology/keab840

Ejemplares similares